Suchergebnisse - "Katakura, Seigo"

PubPharm (21)

1

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer

enthalten in: JAMA oncology | 2024

von Tsukita, Y. | Tozuka, T. | Kushiro, K. | +17

CommentOn: JAMA Oncol. 2024 Apr 1;10(4):433-434. - PMID 38451519

2

Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis

enthalten in: Cancer medicine | 2024

von Murakami, S. | Shinada, K. | Otsutsumi, Y. | +8

3

Investigating EMT-mediated resistance to EGFR tyrosine kinase inhibitors in NSCLC using innovative organoid models

enthalten in: bioRxiv.org | 2024

von Kobayashi, N. | Katakura, S. | Fukuda, N. | +10

4

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis

enthalten in: Cancer Medicine | 2024

von Murakami, S. | Shinada, K. | Otsutsumi, Y. | +8

5

Clinically-meaningful improvements in therapy for unresectable NSCLC

enthalten in: Expert review of anticancer therapy | 2022

von Katakura, S. | Murakami, S.

6

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutations

enthalten in: ResearchSquare.com | 2022

von Murakami, S. | Yokose, T. | Shinada, K. | +7

7

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutations

enthalten in: ResearchSquare.com | 2022

von Murakami, S. | Yokose, T. | Shinada, K. | +7

8

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung : a meta-analysis of diagnostic test accuracy

enthalten in: Therapeutic advances in medical oncology | 2022

von Chen, H. | Katakura, S. | Horita, N. | +6

9

Efforts of Lung Cancer Oncologists in the"With COVID-19"Era

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2021

von Katakura, S. | Kobayashi, N.

10

The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1-49% : a network meta-analysis

enthalten in: Translational lung cancer research | 2021

von Horita, N. | Katakura, S. | Namkoong, H. | +7